The latest announcement is out from Recursion Pharmaceuticals ( ($RXRX) ). On November 26, 2025, Recursion Pharmaceuticals filed a prospectus ...

Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Researchers have used metamathematical techniques to show that certain theorems that look superficially distinct are in fact ...

The habits that led to your promotion — speed, reliability, and having all the answers — are the same habits that will cause ...

ReFantazio director Katsura Hashino claims Japanese role-playing games — often categorized as JRPGs — are entering a new age, ...

The former India cricketer shared his take on rumours suggesting that Kohli will make u-turn from his Test retirement ...

Cursor, which launched one of the fastest-growing AI tools of all time, is at the center of the boom-or-bust debate raging ...